Skip to main content
SpringerLink
Log in

Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Forty-two patients with psoriatic arthritis were included in a multicenter, double-blind trial comparing auranofin and gold sodium thiomalate (GST) for 6 months, followed by a 6-month open treatment. Fifty-two percent of the patients on auranofin and 33% on GST were able to complete the 1-year course of therapy. As a result of the study we conclude that both gold compounds are effective agents in the treatment of psoriatic arthritis. Degree of improvement of arthritis was better in the GST group, but the number of improved patients was greater in the auranofin group. Two patients on auranofin were withdrawn for side effects (one diarrhoea, one worsening of psoriasis) and 5 on GST (rash 2, total loss of appetite 1, exacerbation of psoriasis 2). Comparing the side effects of both compounds, auranofin is less likely to aggravate the psoriatic condition or result in withdrawal of patients for adverse reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barbieri, P., Ciompi, M.L., Bini, C., Pasero, G. Longterm experience with oral gold in psoriatic arthritis. Clin Rheumatol 1986, 5, 274–275.

    Article  PubMed  Google Scholar 

  2. Burdeinyi, A.P., Sigidin, Y.A., Novosyolova, T.M. Therapy of psoriatic arthritis with gold salts (Chrysotherapy). Ter Arkh 1986, 58, 38–43.

    Google Scholar 

  3. Calkins, E. Semiquantitative criteria for estimating degrees of activity of rheumatoid arthritis. Committee report to Amer Rheum Assoc Membership June 1962 (unpubl.) quoted in McCarty D.J. Methods of evaluating rheumatoid arthritis. In: Arthritis and Allied Disorders. Eds.: Hollander, J.L., Mc Carty, Jr. D.J. Lea and Febiger, Philadelphia 1972.

    Google Scholar 

  4. Carette, S., Calin, A., McCafferty, J.P., Wallin, B.A. The Auranofin Cooperating Group: A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum 1989, 32, 158–165.

    PubMed  Google Scholar 

  5. Dequeker, J., Verdickt, W., Gevers, G., Vanschoubroek, K. Long-term experience with oral gold in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 1984, 3, Suppl 1, 67–74.

    Article  Google Scholar 

  6. Dequeker, J., Gevers, G. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis. Scand J Rheumatol 1986, Suppl 63, 85–95.

  7. Dorwart, B.B., Gall, E.P., Schumacher, H.R., Krauser, R.E. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis. Arthritis Rheum 1978, 21, 513–515.

    PubMed  Google Scholar 

  8. Dorwart, B.B., Smukler, N.M., Schumacher, H.R., Zmijewski, et al. Influence of HLA and DR antigens on gold response and toxicity in psoriatic arthritis. Arthritis Rheum 1981, 24, S69 (abstract).

  9. Eccles, J.T., Wright, V. The history and epidemiologic definition of psoriatic arthritis as a distinct entity. In: Psoriatic Arthritis. Ed.: Gerber, L.H., Espinoza, L.R. Grune and Stratton, Orlando 1985.

    Google Scholar 

  10. Farr, M., Kitas, G.D., Waterhouse, L., Jubb, R., Felix-Davies, D., Bacon, P.A. Sulphasalazine in psoriatic arthritis: A double-blind placebo-controlled study. Br J Rheumatol 1990, 29, 46–49.

    PubMed  Google Scholar 

  11. Golding, D.N. Rheumatische Erkrankungen. Thieme, Stuttgart 1971, 175.

    Google Scholar 

  12. Heuer, M.A., Pietrusko, R.G., Morris, R.W., Scheffler, B.J. An analysis of worldwide safety experience with auranofin. J Rheumatol 1985, 12, 695–699.

    PubMed  Google Scholar 

  13. Kammer, G.M., Soter, N.A., Gibson, D.J., Schur, P.H. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Sem Arthr Rheum 1979, 9, 75–97.

    Google Scholar 

  14. Laurent, M.R. Psoriatic arthritis. Clin Rheum Dis 1985, 11, 61–85.

    PubMed  Google Scholar 

  15. Leczinsky, C.G. The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Derm Venereol (Stockh) 1948, 28, 483–487.

    Google Scholar 

  16. Mathies, H. Bericht über die Arbeitstagung in Puerto de la Cruz (Teneriffa) vom 30. November bis 6. Dezember 1969. Arthritis psoriatica. Z Rheumaforschung 1970, 29, 55–58.

    Google Scholar 

  17. Mathies, H. Die parenterale Goldtherapie mit Aureotan und Tauredon. Eular, Basel 1987, 25.

    Google Scholar 

  18. Moll, J.M.H., Wright, V. Psoriatic arthritis. Sem Arthritis Rheum 1973, 3, 55–78.

    Article  Google Scholar 

  19. Müller, W., Brand, S. Parenteral gold therapy in rheumatoid arthritis — efficacy and place in the treatment regimen. Rheumatology. Karger, 1983, 8, 126–147.

    Google Scholar 

  20. Nolting, S., Kastrup, W. Goldtherapie bei Psoriasis arthropathica. Der Hautarzt 1978, 29, 266–269.

    Google Scholar 

  21. Palit, J., Hill, J., Capell, H.A., Carey, J., Daunt, S.O.'N. et al. A multicenter double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990, 29, 280–283.

    PubMed  Google Scholar 

  22. Ragan, C., Tyson, T.L. Chrysotherapy in rheumatoid arthritis. A three-year study of 142 cases. Am J Med 1946, 1, 252–256.

    Article  Google Scholar 

  23. Richter, M.B., Kinsella, P., Corbett, M. Gold in psoriatic arthropathy. Ann Rheum Dis 1980, 39, 279–280.

    PubMed  Google Scholar 

  24. Salvarani, C., Zizzi, F., Macchioni, P., Mantovani, W., Rossi, F. et al. Clinical response to auranofin in patients with psoriatic arthritis. Clin Rheumatol 1989, 8, 54–57.

    Article  Google Scholar 

  25. Schattenkirchner, M., Bröll, H., Kaik, B., Müller-Fassbender, H., Rau, R., Zeidler, H. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: A one-year, double-blind, comparative multicenter study. Klin Wschr 1988, 66, 167–174.

    Article  PubMed  Google Scholar 

  26. Sigler, J.W. Psoriatic arthritis. In: Arthritis and Allied Disorders. Eds.: Hollander, J.L., McCarty, jr. D.J. Lea and Febiger, Philadelphia 1974.

    Google Scholar 

  27. Smith, D.L., Wernick, R. Exacerbation of psoriasis by chrysotherapy. Arch Dermatol 1991, 127, 268–270.

    Article  PubMed  Google Scholar 

  28. Toft, A.B., Manthorpe, R. Guldsaltbehandling af patienter med psoriasis og perifer erosiv arthritis. Ugeskr Laeger 1981, 143, 1400–1401.

    PubMed  Google Scholar 

  29. Tumiati, B., Baricchi, R., Belleli, A. Psoriatic arthritis. Long-term treatment with auranofin. Clin Rheumatol 1986, 5, 124–125.

    Article  PubMed  Google Scholar 

  30. Ward, J.R., Williams, H.J., Boyce, E., Egger, M.J., Reading, J.C., Samuelson, jr. C.O. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1983, 26, 954–971.

    PubMed  Google Scholar 

  31. Wirth, W., Demtröder, F. Langzeitbeobachtungen zu Verlauf, Therapie und Prognose der Psoriasis-Arthritis. Therapiewoche 1985, 35, 3739–3744.

    Google Scholar 

  32. Wright, V. Psoriatic arthritis: a comparative study of rheumatoid arthritis and arthritis associated with psoriasis. Ann Rheum Dis 1961, 20, 123.

    PubMed  Google Scholar 

  33. Zeidler, H. Vergleich von oraler und parenteraler Goldtherapie. Akt Rheumatol 1982, 7, Suppl 3, 184–188.

    Google Scholar 

  34. Zizzi, F., Leghissa, R., Ferruzzi, A., Casadei-Maldini, M., Frizziero, L. A new oral gold salt in the treatment of psoriatic arthritis. Preliminary report in 14 patients after one year's auranofin therapy. Rev Internat Rhumatol 1985, 15, 321–326.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Kernklinik und Poliklinik der Universität Hamburg, Germany

    K. Grasedyck

  2. Rheuma-Einheit der Ludwig-Maximilians-Universität München, Pettenkoferstraße 8a, D-80336, München

    W. Brückle, T. Dexel &  M. Schattenkirchner

Authors
  1. W. Brückle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Dexel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Grasedyck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Schattenkirchner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brückle, W., Dexel, T., Grasedyck, K. et al. Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate. Clin Rheumatol 13, 209–216 (1994). https://doi.org/10.1007/BF02249014

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02249014

Key words

Search

Navigation